Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations
Under a Creative Commons license
open access
Keywords
Folic acid receptor
Long-acting nanoformulated antiretroviral therapy
Human immunodeficiency virus type one
Pharmacokinetics
Pharmacodynamics
Non-obese diabetic severe combined immunodeficient mice
Cited by (0)
Copyright © 2014 The Authors. Published by Elsevier Ltd.